SPDR S&P Biotech Company Profile (NYSEARCA:XBI)

About SPDR S&P Biotech

SPDR S&P Biotech logoSPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

Industry, Sector and Symbol:
  • Sector: Finance
  • Industry: Exchange Traded Fund
  • Sub-Industry: N/A
  • Exchange: NYSEARCA
  • Symbol: XBI
  • CUSIP:
Key Metrics:
  • Previous Close: $68.14
  • 50 Day Moving Average: $63.05
  • 200 Day Moving Average: $57.03
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:
Companies Related to SPDR S&P Biotech:

Analyst Ratings

Consensus Ratings for SPDR S&P Biotech (NYSEARCA:XBI) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for SPDR S&P Biotech (NYSEARCA:XBI)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for SPDR S&P Biotech (NYSEARCA:XBI)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for SPDR S&P Biotech (NYSEARCA:XBI)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for SPDR S&P Biotech (NYSEARCA:XBI)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/19/2015quarterly$0.440.69%6/19/20156/23/20156/29/2015
3/20/2015quarterly$0.250.42%3/20/20153/24/20153/30/2015
12/19/2014quarterly$0.491.03%12/19/201412/23/201412/30/2014
9/19/2014quarterly$0.561.42%9/19/20149/23/20149/29/2014
6/20/2014quarterly$0.621.61%6/20/20146/24/20146/30/2014
3/21/2014quarterly$0.330.87%3/21/20143/25/20143/31/2014
12/20/2013quarterly$0.040.12%12/20/201312/24/201312/31/2013
9/20/2013quarterly$0.090.27%9/20/20139/24/20139/30/2013
3/15/2013quarterly$0.040.18%3/15/20133/19/20133/25/2013
12/21/2012quarterly$0.200.89%12/21/201212/26/20121/4/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for SPDR S&P Biotech (NYSEARCA:XBI)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for SPDR S&P Biotech (NYSEARCA:XBI)
DateHeadline
nasdaq.com logoXBI, SRPT, BLUE, IONS: ETF Inflow Alert - Nasdaq (NYSEARCA:XBI)
www.nasdaq.com - September 24 at 5:46 AM
barrons.com logoBiotech Is Cheaper Than Big Pharma - Barron's (NYSEARCA:XBI)
www.barrons.com - September 24 at 5:46 AM
barrons.com logo[$$] Biotech Is Cheaper Than Big Pharma (NYSEARCA:XBI)
www.barrons.com - September 24 at 5:46 AM
blogs.barrons.com logoGilead Sciences: Another Blow to R&D Strategy - Barron's (blog) (NYSEARCA:XBI)
blogs.barrons.com - September 22 at 7:48 PM
forbes.com logoWednesday's ETF Movers: GDX, XBI - Forbes (NYSEARCA:XBI)
www.forbes.com - September 22 at 7:48 PM
blogs.barrons.com logoGilead Sciences: Another Blow to R&D Strategy (NYSEARCA:XBI)
blogs.barrons.com - September 22 at 7:48 PM
seekingalpha.com logoDeutsche Bank Sinks, While Biotech Soars - Bezek's Daily Briefing - Seeking Alpha (NYSEARCA:XBI)
seekingalpha.com - September 22 at 5:37 AM
finance.yahoo.com logoBiotechnology ETFs Rally on Sarepta FDA Drug Approval - Yahoo Finance (NYSEARCA:XBI)
finance.yahoo.com - September 21 at 7:41 PM
News IconYou Can't Ignore the Biotech Breakout - The Daily Reckoning - Daily Reckoning (NYSEARCA:XBI)
dailyreckoning.com - September 21 at 7:41 PM
nasdaq.com logoBiotech ETFs in Focus on Tobira Therapeutics' Massive Gain - Nasdaq (NYSEARCA:XBI)
www.nasdaq.com - September 21 at 7:41 PM
etfdailynews.com logoThis Biotech ETF is Breaking Out to the Upside - ETF Daily News (blog) (NYSEARCA:XBI)
etfdailynews.com - September 21 at 7:41 PM
marketwatch.com logoCharting the S&P 500’s bullish-leaning holding pattern ahead of the Fed (NYSEARCA:XBI)
www.marketwatch.com - September 21 at 11:59 AM
benzinga.com logoDan Nathan Sees Unusual Options Activity In This Biotech ETF (NYSEARCA:XBI)
www.benzinga.com - September 21 at 11:59 AM
investing.com logoChart Of The Day: Biotech Sector About To Break Out (NYSEARCA:XBI)
www.investing.com - September 21 at 11:59 AM
forbes.com logoTuesday's ETF Movers: XBI, ITB (NYSEARCA:XBI)
www.forbes.com - September 21 at 11:59 AM
etfdailynews.com logoThis Biotech ETF is Breaking Out to the Upside (NYSEARCA:XBI)
etfdailynews.com - September 21 at 11:59 AM
marketrealist.com logoIonis, GlaxoSmithKline Partner on Abnormal Protein Treatment (NYSEARCA:XBI)
marketrealist.com - September 21 at 11:59 AM
finance.yahoo.com logoBiotech ETFs in Focus on Tobira Therapeutics' Massive Gain (NYSEARCA:XBI)
finance.yahoo.com - September 21 at 11:59 AM
forbes.com logoMonday's ETF Movers: XBI, XLF (NYSEARCA:XBI)
www.forbes.com - September 20 at 8:00 AM
mysmartrend.com logoSPDR S&P Biotech ETF Rises 2.72% on Heavy Volume: Watch For Potential Pullback (NYSEARCA:XBI)
www.mysmartrend.com - September 20 at 8:00 AM
forbes.com logoMonday's ETF Movers: XBI, XLF - Forbes (NYSEARCA:XBI)
www.forbes.com - September 19 at 3:15 PM
News IconA Battered Biotech ETF can Rise Again - ETF Trends (NYSEARCA:XBI)
www.etftrends.com - September 17 at 5:51 AM
finance.yahoo.com logoA Battered Biotech ETF can Rise Again (NYSEARCA:XBI)
finance.yahoo.com - September 16 at 11:49 AM
nasdaq.com logoXBI, IONS, MDVN, BLUE: ETF Inflow Alert - Nasdaq (NYSEARCA:XBI)
www.nasdaq.com - September 15 at 8:18 PM
investorplace.com logoSPDR S&P Biotech (ETF) (XBI): The Bears Got Nothin' on Biotech Stocks - Investorplace.com (NYSEARCA:XBI)
investorplace.com - September 15 at 8:18 PM
seekingalpha.com logoBiotechnology: No Easy Way Out But Almost There! (NYSEARCA:XBI)
seekingalpha.com - September 15 at 11:58 AM
mysmartrend.com logoSmarTrend Watching for Potential Pullback in Shares of SPDR S&P Biotech ETF After 2.13% Gain (NYSEARCA:XBI)
www.mysmartrend.com - September 15 at 11:58 AM
investorplace.com logoSPDR S&P Biotech (ETF) (XBI): The Bears Got Nothin’ on Biotech Stocks (NYSEARCA:XBI)
investorplace.com - September 15 at 11:57 AM
blogs.barrons.com logoWhy Gilead Sciences Loves PARP...And You Should Too - Barron's (blog) (NYSEARCA:XBI)
blogs.barrons.com - September 14 at 8:23 PM
marketwatch.com logoSpectrum Pharmaceuticals' stock drops after cancer treatment voted down by FDA committee - MarketWatch (NYSEARCA:XBI)
www.marketwatch.com - September 14 at 8:23 PM
finance.yahoo.com logo9:52 am Biotech (XBI +1.6%, IBB +1%) outperforming (but pulling back intraday) after Allergan (AGN (NYSEARCA:XBI)
finance.yahoo.com - September 14 at 12:34 PM
News IconFinance: Bullish biotech breaks previous highs - Phuket Gazette (NYSEARCA:XBI)
www.phuketgazette.net - September 13 at 5:55 AM
blogs.barrons.com logoAre Biotech ETFs Rallying Based Because Hillary Clinton Has Pneumonia? - Barron's (blog) (NYSEARCA:XBI)
blogs.barrons.com - September 13 at 5:55 AM
News IconWhy Merrimack Pharmaceuticals Inc Fell 20.3% in August | Markets ... - Madison.com (NYSEARCA:XBI)
host.madison.com - September 13 at 5:55 AM
blogs.barrons.com logoBiotech ETFs: Rallying Because Hillary Clinton Has Pneumonia? (NYSEARCA:XBI)
blogs.barrons.com - September 12 at 7:37 PM
News IconFinance: Bullish biotech breaks previous highs (NYSEARCA:XBI)
phuketgazette.net - September 11 at 7:29 PM
marketrealist.com logoHere Are the Latest Analyst Recommendations for Biogen - Market Realist (NYSEARCA:XBI)
marketrealist.com - September 9 at 7:46 PM
marketrealist.com logoHere Are the Latest Analyst Recommendations for Biogen (NYSEARCA:XBI)
marketrealist.com - September 9 at 7:46 PM
investing.com logoHow To Avoid The Worst Sector ETFs 3Q16 | Investing.com - Investing.com (NYSEARCA:XBI)
www.investing.com - September 9 at 5:52 AM
investing.com logoHow To Avoid The Worst Sector ETFs 3Q16 (NYSEARCA:XBI)
www.investing.com - September 8 at 7:47 PM
nasdaq.com logoInsiders Bullish on Certain Holdings of XBI (NYSEARCA:XBI)
www.nasdaq.com - September 8 at 12:06 PM
News IconTechnicals, Politics Clash for Biotech ETFs - ETF Trends (NYSEARCA:XBI)
www.etftrends.com - September 7 at 8:16 PM
investors.com logoOil ETFs Buck Stock Market's Weakness; Gold Rally Pauses - Investor's Business Daily (NYSEARCA:XBI)
www.investors.com - September 7 at 8:16 PM
forbes.com logoXBI: Big ETF Outflows - Forbes (NYSEARCA:XBI)
www.forbes.com - September 7 at 8:16 PM
nasdaq.com logoXBI, DDG: Big ETF Outflows (NYSEARCA:XBI)
www.nasdaq.com - September 7 at 12:04 PM
forbes.com logoXBI: Big ETF Outflows (NYSEARCA:XBI)
www.forbes.com - September 7 at 12:04 PM
marketrealist.com logoUnderstanding Incyte's Revenue Stream in 2Q16 - Market Realist (NYSEARCA:XBI)
marketrealist.com - September 3 at 7:07 PM
marketrealist.com logoIs Incyte Hurt by Having Only One FDA-Approved Drug? - Market Realist (NYSEARCA:XBI)
marketrealist.com - September 3 at 5:43 AM
News Icon3 ETFs to play biotech's bounce back from disaster (NYSEARCA:XBI)
www.fidelity.com - September 2 at 7:59 PM
etfdailynews.com logoCan the Biotech Sector Turn it Around Before Year-End? (NYSEARCA:XBI)
etfdailynews.com - September 2 at 7:59 PM

Social


Last Updated on 9/26/2016 by MarketBeat.com Staff